Press release
Chronic Kidney Disease Competitive Landscape Report 2024 (Updated)
DelveInsight's, "Chronic Kidney Disease Competitive Landscape 2024" report provides comprehensive insights about 75+ Chronic Kidney Disease Companies and 95+ drugs in the Chronic Kidney Disease Competitive landscape. It covers the Chronic Kidney Disease therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Chronic Kidney Disease Competitive Landscape Report
• DelveInsight's Chronic Kidney Disease report depicts a robust space with 75+ Chronic Kidney Disease companies working to develop 95+ therapies for Chronic Kidney Disease treatment.
• The leading Chronic Kidney Disease Companies working in the market include Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, CinCor Pharma, Galapagos NV, Sentien Biotechnologies, Inc., Regeneron Pharmaceuticals, UnicoCell Biomed, OccuRx, Pharmicell, Lisata Therapeutics, Unicycive Therapeutics, Senda Biosciences, Sarfez Pharmaceuticals, Rege Nephro, Orgenesis, GNI Group, Algomedix, Maze Therapeutics, Chinook Therapeutics, Angion Biomedica Corp, Arch Biopartners, Scohia Pharma, Algernon Pharmaceuticals, TICEBA GmbH, and others.
• Promising Chronic Kidney Disease Therapies in the various stages of development include Roxadustat, Monofer®, AZD5718, Dapagliflozin 10 mg, MEDI8367, rHuEPO, AST-120, Epoetin Alfa, and others.
Request a sample and discover the recent advances in Chronic Kidney Disease Drugs @ Chronic Kidney Disease Competitive Landscape- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Chronic Kidney Disease report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Chronic Kidney Disease report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Chronic Kidney Disease Overview
Chronic Kidney Disease is a condition in which kidneys are damaged and cannot filter blood. As a result, extra fluid and waste from the blood remain in the body, potentially leading to various health issues like heart disease and stroke. Chronic Kidney Disease has various levels of seriousness.
Find out more about Chronic Kidney Disease Analytical Perspective: In-depth Commercial Assessment @ Chronic Kidney Disease Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chronic Kidney Disease Companies and Therapies
• AstraZeneca: Forxiga
• Otsuka Pharmaceutical Co., Ltd.: JYNARQUE
• Boehringer Ingelheim: Empagliflozin
• KBP Biosciences: KBP-5074
• Bayer: Runcaciguat
• Regulus Therapeutics: RGLS8429
Chronic Kidney Disease Competitive Landscape
The Chronic Kidney Disease report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Chronic Kidney Disease Report Assessment
• Company Analysis
• Chronic Kidney Disease Therapeutic Assessment
• Chronic Kidney Disease Pipeline Assessment
• Inactive Chronic Kidney Disease Drugs Assessment
• Chronic Kidney Disease Unmet Needs
Learn more about the emerging Chronic Kidney Disease Competitive Landscape @ Chronic Kidney Disease Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Chronic Kidney Disease Report
• Coverage- Global
• Chronic Kidney Disease Companies- Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, CinCor Pharma, Galapagos NV, Sentien Biotechnologies, Inc., Regeneron Pharmaceuticals, UnicoCell Biomed, OccuRx, Pharmicell, Lisata Therapeutics, Unicycive Therapeutics, Senda Biosciences, Sarfez Pharmaceuticals, Rege Nephro, Orgenesis, GNI Group, Algomedix, Maze Therapeutics, Chinook Therapeutics, Angion Biomedica Corp, Arch Biopartners, Scohia Pharma, Algernon Pharmaceuticals, TICEBA GmbH, and others.
• Chronic Kidney Disease Therapies- Roxadustat, Monofer®, AZD5718, Dapagliflozin 10 mg, MEDI8367, rHuEPO, AST-120, Epoetin Alfa, and others.
• Chronic Kidney Disease Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Chronic Kidney Disease Product Developmental Activities, Visit @ Chronic Kidney Disease Research and Development Activities- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Chronic Kidney Disease: Overview
4. Chronic Kidney Disease -Analytical Perspective: In-depth Commercial Assessment
5. Chronic Kidney Disease Competitive Landscape
6. Chronic Kidney Disease Therapeutic Assessment
7. Chronic Kidney Disease: Company and Product Profiles (Marketed Therapies)
8. AstraZeneca
9. Forxiga
10. Chronic Kidney Disease: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. KBP Biosciences
13. KBP-5074
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Bayer
17. Runcaciguat
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Regulus Therapeutics
21. RGLS8429
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Maze Therapeutics
25. APOL1 Programme
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Chronic Kidney Disease Unmet needs
29. Chronic Kidney Disease Market drivers and barriers
30. Appendix
For further information on the Chronic Kidney Disease Report @ Chronic Kidney Disease Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Top Selling Market Research Reports in 2024
stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
pigment epithelial detachment market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Neuroendocrine Tumor Market- https://www.delveinsight.com/report-store/neuroendocrine-tumors-net-market
medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
keloid market- https://www.delveinsight.com/report-store/keloid-market
mouth neoplasms market- https://www.delveinsight.com/report-store/mouth-neoplasms-market
urinary retention market- https://www.delveinsight.com/report-store/urinary-retention-market
sglt2 inhibitors market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
urea cycle disorders market- https://www.delveinsight.com/report-store/urea-cycle-disorders-market
intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
embolotherapy market- https://www.delveinsight.com/report-store/embolotherapy-market
skin neoplasm market- https://www.delveinsight.com/report-store/skin-neoplasms-market
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
bone growth stimulators market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
meningococcal meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
endoscopic ultrasound market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
wilms tumor market- https://www.delveinsight.com/report-store/wilms-tumor-market
Rhabdomyosarcoma market- https://www.delveinsight.com/report-store/rhabdomyosarcoma-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Key Takeaways from the Chronic Kidney Disease Competitive Landscape Report
• DelveInsight's Chronic Kidney Disease report depicts a robust space with 75+ Chronic Kidney Disease companies working to develop 95+ therapies for Chronic Kidney Disease treatment.
• The leading Chronic Kidney Disease Companies working in the market include Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, CinCor Pharma, Galapagos NV, Sentien Biotechnologies, Inc., Regeneron Pharmaceuticals, UnicoCell Biomed, OccuRx, Pharmicell, Lisata Therapeutics, Unicycive Therapeutics, Senda Biosciences, Sarfez Pharmaceuticals, Rege Nephro, Orgenesis, GNI Group, Algomedix, Maze Therapeutics, Chinook Therapeutics, Angion Biomedica Corp, Arch Biopartners, Scohia Pharma, Algernon Pharmaceuticals, TICEBA GmbH, and others.
• Promising Chronic Kidney Disease Therapies in the various stages of development include Roxadustat, Monofer®, AZD5718, Dapagliflozin 10 mg, MEDI8367, rHuEPO, AST-120, Epoetin Alfa, and others.
Request a sample and discover the recent advances in Chronic Kidney Disease Drugs @ Chronic Kidney Disease Competitive Landscape- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Chronic Kidney Disease report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Chronic Kidney Disease report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Chronic Kidney Disease Overview
Chronic Kidney Disease is a condition in which kidneys are damaged and cannot filter blood. As a result, extra fluid and waste from the blood remain in the body, potentially leading to various health issues like heart disease and stroke. Chronic Kidney Disease has various levels of seriousness.
Find out more about Chronic Kidney Disease Analytical Perspective: In-depth Commercial Assessment @ Chronic Kidney Disease Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chronic Kidney Disease Companies and Therapies
• AstraZeneca: Forxiga
• Otsuka Pharmaceutical Co., Ltd.: JYNARQUE
• Boehringer Ingelheim: Empagliflozin
• KBP Biosciences: KBP-5074
• Bayer: Runcaciguat
• Regulus Therapeutics: RGLS8429
Chronic Kidney Disease Competitive Landscape
The Chronic Kidney Disease report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Chronic Kidney Disease Report Assessment
• Company Analysis
• Chronic Kidney Disease Therapeutic Assessment
• Chronic Kidney Disease Pipeline Assessment
• Inactive Chronic Kidney Disease Drugs Assessment
• Chronic Kidney Disease Unmet Needs
Learn more about the emerging Chronic Kidney Disease Competitive Landscape @ Chronic Kidney Disease Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Chronic Kidney Disease Report
• Coverage- Global
• Chronic Kidney Disease Companies- Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, CinCor Pharma, Galapagos NV, Sentien Biotechnologies, Inc., Regeneron Pharmaceuticals, UnicoCell Biomed, OccuRx, Pharmicell, Lisata Therapeutics, Unicycive Therapeutics, Senda Biosciences, Sarfez Pharmaceuticals, Rege Nephro, Orgenesis, GNI Group, Algomedix, Maze Therapeutics, Chinook Therapeutics, Angion Biomedica Corp, Arch Biopartners, Scohia Pharma, Algernon Pharmaceuticals, TICEBA GmbH, and others.
• Chronic Kidney Disease Therapies- Roxadustat, Monofer®, AZD5718, Dapagliflozin 10 mg, MEDI8367, rHuEPO, AST-120, Epoetin Alfa, and others.
• Chronic Kidney Disease Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Chronic Kidney Disease Product Developmental Activities, Visit @ Chronic Kidney Disease Research and Development Activities- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Chronic Kidney Disease: Overview
4. Chronic Kidney Disease -Analytical Perspective: In-depth Commercial Assessment
5. Chronic Kidney Disease Competitive Landscape
6. Chronic Kidney Disease Therapeutic Assessment
7. Chronic Kidney Disease: Company and Product Profiles (Marketed Therapies)
8. AstraZeneca
9. Forxiga
10. Chronic Kidney Disease: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. KBP Biosciences
13. KBP-5074
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Bayer
17. Runcaciguat
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Regulus Therapeutics
21. RGLS8429
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Maze Therapeutics
25. APOL1 Programme
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Chronic Kidney Disease Unmet needs
29. Chronic Kidney Disease Market drivers and barriers
30. Appendix
For further information on the Chronic Kidney Disease Report @ Chronic Kidney Disease Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Top Selling Market Research Reports in 2024
stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
pigment epithelial detachment market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Neuroendocrine Tumor Market- https://www.delveinsight.com/report-store/neuroendocrine-tumors-net-market
medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
keloid market- https://www.delveinsight.com/report-store/keloid-market
mouth neoplasms market- https://www.delveinsight.com/report-store/mouth-neoplasms-market
urinary retention market- https://www.delveinsight.com/report-store/urinary-retention-market
sglt2 inhibitors market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
urea cycle disorders market- https://www.delveinsight.com/report-store/urea-cycle-disorders-market
intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
embolotherapy market- https://www.delveinsight.com/report-store/embolotherapy-market
skin neoplasm market- https://www.delveinsight.com/report-store/skin-neoplasms-market
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
bone growth stimulators market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
meningococcal meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
endoscopic ultrasound market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
wilms tumor market- https://www.delveinsight.com/report-store/wilms-tumor-market
Rhabdomyosarcoma market- https://www.delveinsight.com/report-store/rhabdomyosarcoma-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
